Statistics
Publications
4
Citations
350
H-Index
4
Active since
1983
Ch. Scholz is an author at Universität Hamburg specializing in oncology, molecular oncology, and human epidermal growth factor receptor 2-targeted therapy.
Publications per year
1983–2020
4
4
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker et al. · Leukemia · 2020 · 92 citations · Full text
Life Sciences, Hematology, Oncology +16
1–4 of 4